Bal Pharma Limited — Board Meeting, 27-05-2026: Outcome of Board Meeting

BAL Pharma has announced its board meeting outcome. For FY26, consolidated revenue reached ₹311.66 Cr and net profit was ₹6.32 Cr. A dividend of ₹1.20/share was proposed. The board also approved a preferential issue of 10 lakh warrants to promoters.